Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Matthew N. O’Brien Laramy & Karthik Nagapudi. (2022) Long-acting ocular drug delivery technologies with clinical precedent. Expert Opinion on Drug Delivery 19:10, pages 1285-1301.
Read now
Read now
Kathrine Blom, Ragnheiður Bragadóttir, Magne Sand Sivertsen, Morten Carstens Moe & Øystein Kalsnes Jørstad. (2022) Does Pharmaceutical Compounding of Vascular Endothelial Growth Factor Inhibitors for Intravitreal Use Alter the Risk of Post-injection Endophthalmitis?. Ocular Immunology and Inflammation 30:3, pages 713-716.
Read now
Read now
Arshad M. Khanani, Aamir A. Aziz, Christina Y. Weng, Weijie Violet Lin, Jordyn Vannavong, Jay Chhablani, Carl J. Danzig & Peter K. Kaiser. (2021) Port delivery system: a novel drug delivery platform to treat retinal diseases. Expert Opinion on Drug Delivery 18:11, pages 1571-1576.
Read now
Read now
Articles from other publishers (30)
Song Li & Tatjana C Jakobs. (2023) Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage. Life Science Alliance 6:8, pages e202301976.
Crossref
Crossref
Yuki Hama, Manabu Miyata, Sotaro Ooto, Hiroshi Tamura, Naoko Ueda-Arakawa, Yuki Muraoka, Masahiro Miyake, Ayako Takahashi, Tomotaka Wakazono, Akihito Uji, Kenji Yamashiro & Akitaka Tsujikawa. (2023) Seven-year outcome after 1-year fixed regimen of intravitreal aflibercept injections followed by pro re nata treatment for neovascular age-related macular degeneration. Graefe's Archive for Clinical and Experimental Ophthalmology 261:7, pages 1871-1881.
Crossref
Crossref
Daniele Veritti, Valentina Sarao, Jay Chhablani, Anat Loewenstein, Paolo Lanzetta, Francesco Bandello, Edoardo Midena, Massimo Nicolò, Mariacristina Parravano, Elisabetta Pilotto, Federico Ricci, Giovanni Staurenghi, Gianni Virgili, Jennifer J. Arnold, Albert J. Augustin, Catherine Creuzot-Garcher, Monica Lövestam Adrian, Polona Jaki Mekjavić, Praveen J. Patel, Francisco J. Rodriguez, Ricarda Schumann, Ashish Sharma, Rufino Silva & Javier Zarranz-Ventura. (2023) The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey. Graefe's Archive for Clinical and Experimental Ophthalmology.
Crossref
Crossref
Eric W. Schneider, Mridul K. ThomasFranco M. Recchia, David A. Reichstein & Carl C. Awh. (2023) SUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina 43:5, pages 739-746.
Crossref
Crossref
Julia Vorbeck, Bettina Hohberger & Antonio Bergua. (2022) Endophthalmitis: Ursachen, Erreger, Therapie und Visusverlauf mit Fokus auf Glaukompatienten. Klinische Monatsblätter für Augenheilkunde 240:05, pages 689-696.
Crossref
Crossref
Yasuhiro MoriAkifumi YamamotoAyumi NakagawaTomohiro Hikima & Akiharu Isowaki. (2023) Potential of TAK-593 ophthalmic emulsion for the treatment of age-related macular degeneration. Biological and Pharmaceutical Bulletin.
Crossref
Crossref
Ariel Yuhan Ong, Axelle Rigaudy, Shafak Toufeeq, Julian Robins, Zaid Shalchi, Mandeep Singh Bindra & Peter Charbel Issa. (2021) Intravitreal injections as a leading cause of acute postoperative endophthalmitis—a regional survey in England. Eye 37:1, pages 163-169.
Crossref
Crossref
Monika Kapur, Suvansh Nirula & Mayuresh P. Naik. (2022) Future of anti-VEGF: biosimilars and biobetters. International Journal of Retina and Vitreous 8:1.
Crossref
Crossref
Uwe Wessels, Markus Zadak, Anja Manuela Weidmann, Thomas Stuchly & Kay-Gunnar Stubenrauch. (2022) Preclinical Observations of Systemic and Ocular Antidrug Antibody Response to Intravitreally Administered Drugs. The AAPS Journal 25:1.
Crossref
Crossref
Luis A. Gonzalez-Gonzalez, Jared E. Knickelbein, Bernard H. Doft, G. K. Balasubramani & Stephen Wisniewski. (2022) Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center. International Ophthalmology 43:3, pages 867-876.
Crossref
Crossref
Rupali Singh, Samaneh Davoudi & Steven Ness. (2022) Preventive factors, diagnosis, and management of injection-related endophthalmitis: a literature review. Graefe's Archive for Clinical and Experimental Ophthalmology.
Crossref
Crossref
Geoffrey G. Emerson, Moshiur M. Rahman, Diana H. Kim, Joshua D. Stein & Brian L. VanderBeek. (2021) Board Certification Is Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections. Journal of VitreoRetinal Diseases 6:2, pages 116-121.
Crossref
Crossref
Aishwarya Kundu, Chiungkuang Chen & Sreenivasu Mudumba. 2022. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics. Handbook of Basic and Clinical Ocular Pharmacology and Therapeutics
119
129
.
Almila Sarigul SezenozImren Akkoyun, Fatma HelvaciogluNihan HaberalAttila DagdevirenDidem BacanliGursel YilmazSibel Oto. (2021)
Antiproliferative and Mitochondrial Protective Effects of Apigenin in an Oxygen-Induced Retinopathy
In Vivo
Mouse Model
. Journal of Ocular Pharmacology and Therapeutics 37:10, pages 580-590.
Crossref
Crossref
Yongseok Mun, Seng Chan You, Da Yun Lee, Seok Kim, Yoo-Ri Chung, Kihwang Lee, Ji Hun Song, Young Gun Park, Young Hoon Park, Young-Jung Roh, Se Joon Woo, Kyu Hyung Park, Rae Woong Park, Sooyoung Yoo, Dong-Jin Chang & Sang Jun Park. (2021) Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology. Epidemiology and Health 43, pages e2021097.
Crossref
Crossref
Onnisa Nanegrungsunk & Neil M. Bressler. (2021) Prevention of vision-threatening complications in diabetic retinopathy: two perspectives based on results from the DRCR Retina Network Protocol W and the Regeneron-sponsored PANORAMA. Current Opinion in Ophthalmology 32:6, pages 590-598.
Crossref
Crossref
Linda A. Lam, Sonia Mehta, Eleonora M. Lad, Geoffrey G. Emerson, J. Michael Jumper & Carl C. Awh. (2021) Intravitreal Injection Therapy: Current Techniques and Supplemental Services. Journal of VitreoRetinal Diseases 5:5, pages 438-447.
Crossref
Crossref
Ferhina S. Ali, Thomas L. Jenkins, Ranjodh S. Boparai, Anthony Obeid, Martha E. Ryan, Turner D. Wibblesman, Allen Chiang, Sunir J. Garg, Hannah J. Levin, David Xu, Ravi R. Pandit, Marc Spirn, Carl Park, Mitchell S. Fineman, James F. Vander, Sonia Mehta, Arunan Sivalingam, Jason Hsu, Allen C. Ho & Carl D. Regillo. (2021) Aqueous Chlorhexidine Compared with Povidone-Iodine as Ocular Antisepsis before Intravitreal Injection: A Randomized Clinical Trial. Ophthalmology Retina 5:8, pages 788-796.
Crossref
Crossref
James Lin, Allister Gibbons & William E. Smiddy. (2021) Cost-Utility of Anti–Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion. Ophthalmology Retina 5:7, pages 656-663.
Crossref
Crossref
Emilio Iturriaga-Goyon, Beatriz Buentello-Volante, Fátima Sofía Magaña-Guerrero & Yonathan Garfias. (2021) Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis. Cells 10:6, pages 1455.
Crossref
Crossref
Dilsher S. Dhoot, Nick Boucher, John D. PitcherIIIIII & Namrata Saroj. (2021) Rates of Suspected Endophthalmitis Following Intravitreal Injections in Clinical Practices in the United States. Ophthalmic Surgery, Lasers and Imaging Retina 52:6, pages 312-318.
Crossref
Crossref
William G. Schultheis, James E. Sharpe, Qiang Zhang, Samir N. Patel, Ajay E. Kuriyan, Allen Chiang, Sunir J. Garg & Jason Hsu. (2021) Effect of Taping Face Masks on Quantitative Particle Counts Near the Eye: Implications for Intravitreal Injections in the COVID-19 Era. American Journal of Ophthalmology 225, pages 166-171.
Crossref
Crossref
Ryan A. Shields, Ivan J. Lee, Meghan M. Brown, Libing K. Dong, Ramon Lee, Christianne A. Wa & Tarek S. Hassan. (2021) Clinical Course and Characteristics of Eyes with Recurrent Episodes of Endophthalmitis. Ophthalmology Retina 5:1, pages 10-15.
Crossref
Crossref
Nicole Koulisis, Stavros N. Moysidis, Viren K. Govindaraju, Anne Merrylees Dersch, Antonio Capone, Douglas J. Covert, Hajir Dadgostar, A. Bawa Dass, Kimberly A. Drenser, Robert E. Engstrom, Lisa J. Faia, Bruce R. Garretson, Amir H. Guerami, Thomas A. Hanscom, Tamer H. Mahmoud, Alan R. Margherio, Kean T. Oh, Sandeep Randhawa, Paul V. Raphaelian, William R. Rhoades, Alan J. Ruby, Christian J. Sanfilippo, Scott R. Sneed, Michael T. Trese, Jeremy D. Wolfe, George A. Williams, Sunita Yedavally & Tarek S. Hassan. (2020) Clinical Outcomes And Treatment Course of Eyes with Neovascular Age-Related Macular Degeneration Following the Development of Endophthalmitis. Retina Publish Ahead of Print.
Crossref
Crossref
Ashish Sharma, Nilesh Kumar, Nikulaa Parachuri, Rohini Sharma, Francesco Bandello, Baruch D. Kuppermann & Anat Loewenstein. (2020) Brolucizumab and immunogenicity. Eye 34:10, pages 1726-1728.
Crossref
Crossref
Laiqing Xie, Xiaoyan Ji, Yuanyuan Tu, Kun Wang, Linling Zhu, Xinwei Zeng, Xue Wang, Ji Zhang & Manhui Zhu. (2020) MLN4924 inhibits hedgehog signaling pathway and activates autophagy to alleviate mouse laser-induced choroidal neovascularization lesion. Biomedicine & Pharmacotherapy 130, pages 110654.
Crossref
Crossref
Shriji N. Patel, Sapna Gangaputra, Paul SternbergJr.Jr. & Stephen J. Kim. (2020) Prophylaxis measures for postinjection endophthalmitis. Survey of Ophthalmology 65:4, pages 408-420.
Crossref
Crossref
Landon J. Rohowetz, Nicolas A. Yannuzzi, Sunil Gupta, Nimesh A. Patel, Darlene Miller & Harry W. Flynn Jr.. (2020) Endophthalmitis Caused by <b><i>Agrobacterium radiobacter</i></b> following Intravitreal Aflibercept for Diabetic Retinopathy. Case Reports in Ophthalmology 11:1, pages 22-27.
Crossref
Crossref
Avinash Honasoge, Eric Nudleman, Morton Smith & Rithwick Rajagopal. (2019) Emerging Insights and Interventions for Diabetic Retinopathy. Current Diabetes Reports 19:10.
Crossref
Crossref
Ashish Sharma, Nilesh Kumar, Baruch D. Kuppermann, Francesco Bandello & Anat Loewenstein. (2019) Biotherapeutics and immunogenicity: ophthalmic perspective. Eye 33:9, pages 1359-1361.
Crossref
Crossref